Found: 3
Select item for more details and to access through your institution.
Control of disease activity with large extended-interval dosing of rituximab/ocrelizumab in highly active pediatric multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 2, p. 261, doi. 10.1177/13524585231223069
- By:
- Publication type:
- Article
Early blood neurofilament light chain and myelin oligodendrocyte glycoprotein antibody levels associate with different disease courses of myelin oligodendrocyte glycoproteinassociated disease in children.
- Published in:
- Brain Communications, 2023, v. 5, n. 2, p. 1, doi. 10.1093/braincomms/fcad063
- By:
- Publication type:
- Article
Regulatory T Cells Increase After rh-MOG Stimulation in Non-Relapsing but Decrease in Relapsing MOG Antibody-Associated Disease at Onset in Children.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.679770
- By:
- Publication type:
- Article